BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36723879)

  • 1. High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data.
    Bundschuh RA; Lütje S; Bundschuh L; Lapa C; Higuchi T; Hartrampf PE; Gorin MA; Kosmala A; Buck AK; Pomper MG; Rowe SP; Essler M; Sheikh GT; Werner RA
    Clin Nucl Med; 2023 Mar; 48(3):207-212. PubMed ID: 36723879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interobserver Agreement for the Standardized Reporting System PSMA-RADS 1.0 on
    Werner RA; Bundschuh RA; Bundschuh L; Javadi MS; Leal JP; Higuchi T; Pienta KJ; Buck AK; Pomper MG; Gorin MA; Lapa C; Rowe SP
    J Nucl Med; 2018 Dec; 59(12):1857-1864. PubMed ID: 30190304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients.
    Grawe F; Blom F; Winkelmann M; Burgard C; Schmid-Tannwald C; Unterrainer LM; Sheikh GT; Pfitzinger PL; Kazmierczak P; Cyran CC; Ricke J; Stief CG; Bartenstein P; Ruebenthaler J; Fabritius MP; Geyer T
    Eur Radiol; 2024 Feb; 34(2):1157-1166. PubMed ID: 37624414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and Therapy.
    Hartrampf PE; Kosmala A; Serfling SE; Bundschuh L; Higuchi T; Lapa C; Rowe SP; Matsusaka Y; Weich A; Buck AK; Bundschuh RA; Werner RA
    Clin Nucl Med; 2023 Jun; 48(6):483-488. PubMed ID: 36947793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT.
    Werner RA; Derlin T; Rowe SP; Bundschuh L; Sheikh GT; Pomper MG; Schulz S; Higuchi T; Buck AK; Bengel FM; Bundschuh RA; Lapa C
    J Nucl Med; 2021 Apr; 62(4):514-520. PubMed ID: 32859702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy.
    Serfling SE; Hartrampf PE; Zhi Y; Higuchi T; Rowe SP; Bundschuh L; Essler M; Buck AK; Bundschuh RA; Werner RA
    Clin Nucl Med; 2022 Jun; 47(6):512-516. PubMed ID: 35439187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria.
    Demirci E; Akyel R; Caner B; Alan-Selçuk N; Güven-Meşe Ş; Ocak M; Kabasakal L
    Nucl Med Commun; 2020 Aug; 41(8):759-767. PubMed ID: 32453205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A VISION Substudy of Reader Agreement on
    Kuo PH; Yoo DC; Avery R; Seltzer M; Calais J; Nagarajah J; Weber WA; Fendler WP; Hofman MS; Krause BJ; Brackman M; Kpamegan E; Ghebremariam S; Benson T; Catafau AM; Kendi AT
    J Nucl Med; 2023 Aug; 64(8):1259-1265. PubMed ID: 37230533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interobserver agreement of [
    Derwael C; Lavergne O; Lovinfosse P; Nechifor V; Salvé M; Waltregny D; Hustinx R; Withofs N
    EJNMMI Res; 2020 Feb; 10(1):15. PubMed ID: 32112230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    De Man K; Van Laeken N; Schelfhout V; Fendler WP; Lambert B; Kersemans K; Piron S; Lumen N; Decaestecker K; Fonteyne V; Delrue L; De Vos F; Ost P
    Eur Urol; 2022 Nov; 82(5):501-509. PubMed ID: 35690515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of [
    Mingels C; Bohn KP; Rominger A; Afshar-Oromieh A; Alberts I
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2436-2444. PubMed ID: 35067735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined forced diuresis and late acquisition on [
    Bauckneht M; Miceli A; Signori A; Albano D; Capitanio S; Piva R; Laudicella R; Franchini A; D'Amico F; Riondato M; Chiola S; Marini C; Fornarini G; Scarale A; Muni A; Bertagna F; Burger IA; Sambuceti G; Morbelli S
    Eur Radiol; 2023 May; 33(5):3343-3353. PubMed ID: 36892650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on
    Garg T; Werner RA; Chung HW; Khatri W; Pienta KJ; Pomper MG; Gorin MA; Saad E; Rowe SP
    Tomography; 2022 Oct; 8(6):2639-2647. PubMed ID: 36412679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallium-68-prostate-specific membrane antigen (
    van Leeuwen PJ; Donswijk M; Nandurkar R; Stricker P; Ho B; Heijmink S; Wit EMK; Tillier C; van Muilenkom E; Nguyen Q; van der Poel HG; Emmett L
    BJU Int; 2019 Jul; 124(1):62-68. PubMed ID: 30074667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 Patients.
    Fendler WP; Barrio M; Spick C; Allen-Auerbach M; Ambrosini V; Benz M; Bluemel C; Grewal RK; Lapa C; Miederer M; Nicolas G; Schuster T; Czernin J; Herrmann K
    J Nucl Med; 2017 Feb; 58(2):307-311. PubMed ID: 27539839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Hirmas N; Al-Ibraheem A; Herrmann K; Alsharif A; Muhsin H; Khader J; Al-Daghmin A; Salah S
    Mol Imaging Biol; 2019 Jun; 21(3):574-581. PubMed ID: 30215174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
    Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.